13 April in the Indian stock market
What our records show for 13 April: the Nifty 50's close in each year we hold, companies that first listed on this date, bonus issues and splits that went ex, and symbol changes.
- Nifty 50 by year
- Listings
- Bonuses and splits
- Symbol changes
Nifty 50 closes
4
years with a close on 13 April
Listings
3
companies first traded on this date
Bonuses and splits
2
went ex on this date
Symbol changes
2
took effect on this date
Nifty 50 on 13 April, by year
| Year | Close | Change on the day |
|---|---|---|
| 2026 | 23,842.65 | −0.86% |
| 2023 | 17,828.00 | +0.09% |
| 2022 | 17,475.65 | −0.31% |
| 2021 | 14,504.80 | +1.36% |
Price index, as published by NSE. Weekends and market holidays have no close, so some years are missing.
Listed on this date
- 2022HARIOMPIPE Hariom Pipe Industries Limited
- 2007ICRA ICRA Limited
- 2006KKCL Kewal Kiran Clothing Limited
Companies listed on NSE today whose first trading day was this date. The latest 12.
Bonuses and splits, ex-date
- 2018AMRUTANJAN Split, face value ₹2 to ₹1
- 2012SUNDARAM Bonus 2:1
Of companies listed today. The latest 12.
Symbol changes
Old symbol to the symbol it trades under today. The latest 12.
Questions
- How did the Nifty 50 move on 13 April in past years?
- The Nifty 50 closed at these levels on 13 April in the years our records hold, with the change on the day in brackets. 2021: 14,504.80 (+1.36%); 2022: 17,475.65 (−0.31%); 2023: 17,828.00 (+0.09%); 2026: 23,842.65 (−0.86%). Weekends and holidays have no close.
- Which companies listed on NSE on 13 April?
- Companies that are listed today and first traded on 13 April include Kewal Kiran Clothing Limited (2006), ICRA Limited (2007), Hariom Pipe Industries Limited (2022).
- Which bonus issues and splits had an ex-date on 13 April?
- SUNDARAM in 2012: Bonus 2:1; AMRUTANJAN in 2018: Split, face value ₹2 to ₹1.
Pick another day
Educational data from NSE, not investment advice, research or a recommendation to buy, sell or hold any security. Past performance does not indicate future results. Read the Disclaimer.